Scientists have developed new technology, Alzheimer's will already know!

Scientists have developed new technology, Alzheimer's will already know!


Scientists have designed such artificial intelligence (AI or Artificial Intelligence) algorithm, which can be used to determine whether a person is at risk of Alzheimer's in the next five years due to lack of thinking and ability. One of these scientists is of Indian origin.

Researchers at the University of Toronto in Canada have designed an algorithm that understands signals from magnetic resonance imaging (MRI), genetics, and clinical data.


According to a research published in PLOS Computational Biology, 'The said algorithm can help in finding out if there is a possibility of Alzheimer's disease in the next five years due to the lack of understanding of the person'.

Assistant professor at McGill University in Canada, Malar Chakraborty said, "Currently, there are limited methods of treating Alzheimer's and the best is prevention." The artificial intelligence process may have an important role as a medical assistant. With this help people can follow the right direction for treatment '.

He said that on the basis of estimates, people can make lifestyle changes so that Alzheimer's can be avoided, or it is possible to stop it altogether.

This research involved 800 people, some of whom had normal health, some had a slight decline in their ability to understand and some who were suffering from Alzheimer's.



Scientists have prepared a new drug, its consumption will not cause Alzheimer's


Scientists have discovered a new drug. The special thing of this medicine is that it can protect from memory loss, nerve damage and other symptoms of Alzheimer's disease.

The report of this preclinical research has been published in the Journal of Pharmacology and Experimental Therapeutics. It was found that the drug-BPN14770-inhibits the effects of amyloid beta. Amloid beta is a hallmark of Alzheimer's protein, which is toxic to nerve cells.

BPN 14770, under the development of tetra therapics, can help activate processes that aid nerve health and prevent dementia.


Researcher Ying Xu, associate professor at Bufalo University, said, "Such observation means that Alzheimer's pathology can be tolerated to some extent by the brain, due to the compensatory process running at the cellular and synaptic levels." is."

Xu said, "According to our new research, BPN 14770 may be able to activate multiple biological processes, these processes prevent the brain from loss of memory, neurological damage and biochemical impairment."

Comments